Dr. Emancia Neil , MD
General Practice • Bronx, NY
1571 Sheridan Ave, Suite 4b
Bronx, NY 104578546
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 5, 2007; this date does not establish years in practice.
-
Published CMS data list 496 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Metformin Hcl — 65 prescription fills, including refills.
- Pioglitazone Hcl — 60 prescription fills, including refills.
- Ozempic (Semaglutide) — 49 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 19 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Bronx, NY (2024, 24 clinicians with data). Median for this group: 703. Middle half: 49 to 3,699.
Close to the middle for Part D prescriptions among clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: 462. Middle half: 50 to 2,510.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 237 in 2020 to 496 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
1571 Sheridan Ave
Suite 4b
Bronx, NY 104578546
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Rutgers New Jersey Medical School
1995
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
772 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$142,860 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $157.75 across 6 records.
By nature of payment
- Food and Beverage: $157.75 across 6 records.
Reporting-company totals
- Novo Nordisk Inc: $72.88 across 3 records.
- Eli Lilly and Company: $63.64 across 2 records.
- Amgen Inc.: $21.23 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
31 years (graduated 1995)
CMS Doctors and Clinicians data list 1995 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Neil has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Neil as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bronx and New York
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Bronx, NY (2024, 24 clinicians with data). Median for this group: 703. Middle half: 49 to 3,699.
Close to the middle for clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: 462. Middle half: 50 to 2,510.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under General Practice in Bronx, NY (2024, 24 clinicians with data). Median for this group: $71,036. Middle half: $1,226 to $240,700.
A higher Part D drug cost than 65% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: $29,331. Middle half: $1,020 to $209,203.
79 active clinicians are listed under General Practice with a practice address in Bronx, NY (682 in New York).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bronx
8.9% of these 79 clinicians have the CMS telehealth indicator.
25.3% of these 79 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 109% from 237 in 2020 to 496 in 2024.
- 2020: 237
- 2021: 328
- 2022: 207
- 2023: 384
- 2024: 496
-
30-day fills
30-day fills increased 74% from 443 in 2020 to 772 in 2024.
- 2020: 443
- 2021: 572
- 2022: 428
- 2023: 619
- 2024: 772
-
Part D drug cost
Part D drug cost increased 145% from $58,414 in 2020 to $142,860 in 2024.
- 2020: $58,414
- 2021: $89,979
- 2022: $62,043
- 2023: $76,721
- 2024: $142,860
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $788.29 in 2021 to $157.75 in 2025.
- 2021: $788.29
- 2022: $374.79
- 2023: $131.19
- 2024: $458.01
- 2025: $157.75
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $157.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $34.04 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $29.60 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $25.57 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $24.69 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $22.62 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $21.23 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Metformin Hcl | Metformin Hcl | 65 | 2,767 | $336.81 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 60 | 2,557 | $446.94 | 15 |
| Ozempic | Semaglutide | 49 | 1,540 | $50,204.26 | — |
| Amlodipine Besylate | Amlodipine Besylate | 37 | 2,550 | $231.64 | 12 |
| Ramipril | Ramipril | 31 | 1,394 | $139.76 | — |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 30 | 1,417 | $1,026.72 | — |
| Mounjaro | Tirzepatide | 30 | 1,400 | $50,909.91 | — |
| Trulicity | Dulaglutide | 25 | 700 | $22,868.14 | — |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | 784 | $26.56 | — |
| Carvedilol | Carvedilol | 21 | 1,530 | $213.38 | — |
| Omeprazole | Omeprazole | 19 | 870 | $65.31 | — |
| Losartan Potassium | Losartan Potassium | 17 | 1,110 | $198.42 | — |
| Simvastatin | Simvastatin | 14 | 780 | $119.12 | — |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | 810 | $117.34 | — |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | 357 | $104.35 | — |
| Viracept | Nelfinavir Mesylate | 13 | 390 | $15,528.24 | — |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | 517 | $150.14 | — |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 12 | 496 | $41.92 | — |
| Ezetimibe | Ezetimibe | 11 | 810 | $131.49 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - FAMILY PRACTICE
I20040223001272
NY
6204722770
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated June 05, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Bronx
- Dr. Georges Ramalanjaona, MD
- Dr. Keith Fratta, MD
- Dr. Emine Cosar, MD
- Dr. Nighat Fazili, MD
- Dr. Shabnam Pourabolghasem, MD
- Dr. Leila Mahdavian, MD
Mailing Address
1571 Sheridan Ave, Suite 4b
Bronx, NY 104578546
Phone: 7184660430